The prospects “the possibilities for domestic pharmaceutical companies to enter into advanced markets”

The prospects that say the possibilities for domestic pharmaceutical companies to enter into advanced markets are growing have come out.

An analyst Hyuntae Kim of Daewoo Securities revealed that Dong-A EST and Celltrion had encouraging results in getting approval from the US and Japan through the pharmaceutical industry analysis report on September 16. He also revealed that since Mezzion and G...